• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

18F-FDG-PET/CT引导的靶区勾画在局部晚期鼻咽癌中的预后相关性:一项比较研究

Prognostic Relevance of 18F-FDG-PET/CT-Guided Target Volume Delineation in Loco-Regionally Advanced Nasopharyngeal Carcinomas: A Comparative Study.

作者信息

Yan Ouying, Wang Hui, Han Yaqian, Fu Shengnan, Chen Yanzhu, Liu Feng

机构信息

Department of Radiation Oncology, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.

The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.

出版信息

Front Oncol. 2021 Aug 23;11:709622. doi: 10.3389/fonc.2021.709622. eCollection 2021.

DOI:10.3389/fonc.2021.709622
PMID:34497763
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8419252/
Abstract

INTRODUCTION

An optimal approach to define tumor volume in locoregionally advanced nasopharyngeal carcinoma (NPC) using 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) remains unclear. This retrospective study aimed at comparing the outcomes and toxicities of different FDG-PET/CT-guided techniques for primary tumor volume delineation in locoregionally advanced NPC.

METHODS

From August 2015 to February 2018, 292 patients with stage III-IVB NPC received FDG-PET/CT-guided IMRT. Three PET/CT-based techniques were used to determine the gross tumor volume (GTV) as follows: visual criteria (group A; n = 98), a standard uptake value (SUV) threshold of 2.5 (group B; n = 95), and a threshold of 50% maximal intensity (group C, n = 99) combined with a dose-painting technique.

RESULTS

In groups A, B, and C, the 5-year LRFS rates were 89.4%, 90.0%, and 97.8%, respectively (p = 0.043). The 5-year DMFS rates were 75.1%, 76.0%, and 87.7%, respectively (p = 0.043). The 5-year DFS rates were 70.9%, 70.3%, and 82.2%, respectively (p = 0.048). The 5-year OS rates were 73.5%, 73.9%, and 84.9%, respectively (p = 0.038). Group C showed significantly higher 5-year LRFS, LRRFS, DMFS, DFS, and OS than those in groups A and B (p < 0.05). No statistically significant differences were observed between the three study groups in the cumulative incidences of grade 3-4 acute and late toxicities. Multivariate analyses showed that the PET/CT-guided technique for target volume delineation was an independent prognostic factor for 5-year LRFS, DFS, DMFS, and OS (p = 0.039, p = 0.030, p = 0.035 and p = 0.028, respectively), and was marginally significant in predicting LRRFS (p = 0.080).

CONCLUSIONS

The 50% SUVmax threshold regimen for GTV delineation with dose-painting appeared to be superior to the visual criteria or SUV2.5 threshold in locoregionally advanced NPC, and there was no increased toxicity.

摘要

引言

使用18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG-PET/CT)来定义局部晚期鼻咽癌(NPC)肿瘤体积的最佳方法仍不明确。本回顾性研究旨在比较不同FDG-PET/CT引导技术在局部晚期NPC中勾画原发肿瘤体积的疗效和毒性。

方法

2015年8月至2018年2月,292例III-IVB期NPC患者接受了FDG-PET/CT引导的调强放疗(IMRT)。采用三种基于PET/CT的技术来确定大体肿瘤体积(GTV),具体如下:视觉标准(A组;n = 98)、标准摄取值(SUV)阈值为2.5(B组;n = 95)以及最大强度的50%阈值(C组,n = 99)并结合剂量描绘技术。

结果

A组、B组和C组的5年局部区域无复发生存率(LRFS)分别为89.4%、90.0%和97.8%(p = 0.043)。5年远处无转移生存率(DMFS)分别为75.1%、76.0%和87.7%(p = 0.043)。5年无病生存率(DFS)分别为70.9%、70.3%和82.2%(p = 0.048)。5年总生存率(OS)分别为73.5%、73.9%和84.9%(p = 0.038)。C组的5年LRFS、局部区域复发无复发生存率(LRRFS)、DMFS、DFS和OS均显著高于A组和B组(p < 0.05)。三个研究组在3-4级急性和晚期毒性的累积发生率方面未观察到统计学显著差异。多因素分析显示,PET/CT引导的靶区勾画技术是5年LRFS、DFS、DMFS和OS的独立预后因素(分别为p = 0.039、p = 0.030、p = 0.035和p = 0.028),在预测LRRFS方面边缘显著(p = 0.080)。

结论

采用剂量描绘的GTV勾画50%SUVmax阈值方案在局部晚期NPC中似乎优于视觉标准或SUV2.5阈值,且毒性未增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cbe/8419252/f4b53a953ea2/fonc-11-709622-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cbe/8419252/f4b53a953ea2/fonc-11-709622-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cbe/8419252/f4b53a953ea2/fonc-11-709622-g001.jpg

相似文献

1
Prognostic Relevance of 18F-FDG-PET/CT-Guided Target Volume Delineation in Loco-Regionally Advanced Nasopharyngeal Carcinomas: A Comparative Study.18F-FDG-PET/CT引导的靶区勾画在局部晚期鼻咽癌中的预后相关性:一项比较研究
Front Oncol. 2021 Aug 23;11:709622. doi: 10.3389/fonc.2021.709622. eCollection 2021.
2
PET/CT-guided dose-painting versus CT-based intensity modulated radiation therapy in locoregional advanced nasopharyngeal carcinoma.18F-FDG PET/CT引导的剂量引导放疗与基于CT的调强放疗在局部晚期鼻咽癌中的应用比较
Radiat Oncol. 2017 Jan 13;12(1):15. doi: 10.1186/s13014-016-0739-y.
3
Positron emission tomography-computed tomography before treatment is highly prognostic of distant metastasis in nasopharyngeal carcinoma patients after intensity-modulated radiotherapy treatment: a prospective study with long-term follow-up.治疗前正电子发射断层扫描-计算机断层扫描对鼻咽癌患者调强放疗后的远处转移具有高度预后价值:一项长期随访的前瞻性研究
Oral Oncol. 2015 Apr;51(4):363-9. doi: 10.1016/j.oraloncology.2015.01.009. Epub 2015 Feb 2.
4
Use of F-FDG PET/CT Imaging for Radiotherapy Target Volume Delineation after Induction Chemotherapy and for Prognosis of Locally Advanced Squamous Cell Carcinoma of the Head and Neck.F-FDG PET/CT成像在诱导化疗后对头颈部局部晚期鳞状细胞癌放疗靶区勾画及预后评估中的应用。
Medicina (Kaunas). 2018 Dec 10;54(6):107. doi: 10.3390/medicina54060107.
5
Prognostic value and predictive threshold of tumor volume for patients with locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiotherapy.局部晚期鼻咽癌患者接受调强放疗时肿瘤体积的预后价值及预测阈值
Chin J Cancer. 2016 Nov 16;35(1):96. doi: 10.1186/s40880-016-0159-2.
6
Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.治疗前 18F-FDG PET/CT 最大标准化摄取值对局部晚期头颈部鳞状细胞癌的预后价值。
Clin Transl Oncol. 2017 Nov;19(11):1337-1349. doi: 10.1007/s12094-017-1674-6. Epub 2017 May 24.
7
Prognostic value of primary gross tumor volume and standardized uptake value of F-FDG in PET/CT for distant metastasis in locoregionally advanced nasopharyngeal carcinoma.PET/CT中F-FDG的原发肿瘤大体体积和标准化摄取值对局部区域晚期鼻咽癌远处转移的预后价值。
Tumour Biol. 2017 Jul;39(7):1010428317717843. doi: 10.1177/1010428317717843.
8
Role of pretreatment 18F-FDG PET/CT parameters in predicting outcome of non-endemic EBV DNA-related nasopharyngeal cancer (NPC) patients treated with IMRT and chemotherapy.预处理 18F-FDG PET/CT 参数在预测接受调强放疗和化疗的非地方性 EBV DNA 相关鼻咽癌(NPC)患者结局中的作用。
Radiol Med. 2019 May;124(5):414-421. doi: 10.1007/s11547-018-0980-6. Epub 2018 Dec 17.
9
FDG-PET/CT Predicts Outcome in Oropharingeal Carcinoma Patients Undergoing Intensity Modulated Radiation Therapy with Dose Escalation to FDG-avid Tumour Volumes.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG-PET/CT)可预测接受调强放疗并对FDG摄取阳性肿瘤体积进行剂量递增的口咽癌患者的预后。
Curr Radiopharm. 2017 Aug 24;10(2):102-110. doi: 10.2174/1874471010666170413151108.
10
The Role of the Metabolic Parameters of F-FDG PET/CT in Patients With Locally Advanced Cervical Cancer.F-FDG PET/CT代谢参数在局部晚期宫颈癌患者中的作用
Front Oncol. 2021 Aug 19;11:698744. doi: 10.3389/fonc.2021.698744. eCollection 2021.

引用本文的文献

1
DWI-guided DP-IMRT and conventional MRI-based IMRT in head and neck squamous cell carcinoma: a comparative study.弥散加权成像引导的调强适形放疗与基于传统磁共振成像的调强适形放疗在头颈部鳞状细胞癌中的比较研究
BMC Cancer. 2025 Aug 23;25(1):1364. doi: 10.1186/s12885-025-14684-x.
2
Embracing Personalized Strategies in Radiotherapy for Nasopharyngeal Carcinoma: Beyond the Conventional Bounds of Fields and Borders.鼻咽癌放疗中采用个性化策略:超越传统射野和边界的局限
Cancers (Basel). 2024 Jan 16;16(2):383. doi: 10.3390/cancers16020383.
3
Prognostic potential of a voxelwise invasion risk map of nasopharyngeal carcinoma based on a coordinate system of the nasopharynx.

本文引用的文献

1
Pretreatment F-FDG uptake heterogeneity can predict treatment outcome of carbon ion radiotherapy in patients with locally recurrent nasopharyngeal carcinoma.治疗前 F-FDG 摄取异质性可预测局部复发性鼻咽癌碳离子放疗的治疗效果。
Ann Nucl Med. 2021 Jul;35(7):834-842. doi: 10.1007/s12149-021-01621-8. Epub 2021 Apr 28.
2
Combing MRI Perfusion and F-FDG PET/CT Metabolic Biomarkers Helps Predict Survival in Advanced Nasopharyngeal Carcinoma: A Prospective Multimodal Imaging Study.联合MRI灌注与F-FDG PET/CT代谢生物标志物有助于预测晚期鼻咽癌的生存率:一项前瞻性多模态成像研究
Cancers (Basel). 2021 Mar 28;13(7):1550. doi: 10.3390/cancers13071550.
3
基于鼻咽坐标系的鼻咽癌体素侵袭风险图的预后潜力
Quant Imaging Med Surg. 2023 Feb 1;13(2):982-998. doi: 10.21037/qims-22-744. Epub 2023 Jan 5.
Prediction of local recurrence and distant metastasis using radiomics analysis of pretreatment nasopharyngeal [18F]FDG PET/CT images.
基于治疗前鼻咽部 [18F]FDG PET/CT 图像的放射组学分析预测局部复发和远处转移。
Ann Nucl Med. 2021 Apr;35(4):458-468. doi: 10.1007/s12149-021-01585-9. Epub 2021 Feb 4.
4
Nomogram for the prediction of primary distant metastasis of nasopharyngeal carcinoma to guide individualized application of FDG PET/CT.预测鼻咽癌原发远处转移的列线图,以指导 FDG PET/CT 的个体化应用。
Eur J Nucl Med Mol Imaging. 2021 Jul;48(8):2586-2598. doi: 10.1007/s00259-020-05128-8. Epub 2021 Jan 8.
5
The Association Between the Development of Radiation Therapy, Image Technology, and Chemotherapy, and the Survival of Patients With Nasopharyngeal Carcinoma: A Cohort Study From 1990 to 2012.放疗、影像技术和化疗的发展与鼻咽癌患者生存的关系:一项 1990 年至 2012 年的队列研究。
Int J Radiat Oncol Biol Phys. 2019 Nov 1;105(3):581-590. doi: 10.1016/j.ijrobp.2019.06.2549. Epub 2019 Jul 15.
6
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma.吉西他滨和顺铂诱导化疗治疗鼻咽癌。
N Engl J Med. 2019 Sep 19;381(12):1124-1135. doi: 10.1056/NEJMoa1905287. Epub 2019 May 31.
7
Depicting distant metastatic risk by refined subgroups derived from the 8th edition nasopharyngeal carcinoma TNM.通过第 8 版鼻咽癌 TNM 衍生的精细亚组描绘远处转移风险。
Oral Oncol. 2019 Apr;91:113-120. doi: 10.1016/j.oraloncology.2019.02.021. Epub 2019 Mar 12.
8
Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study).香港调强放疗时代鼻咽癌的治疗结果:3328 例患者报告(HKNPCSG 1301 研究)。
Oral Oncol. 2018 Feb;77:16-21. doi: 10.1016/j.oraloncology.2017.12.004. Epub 2017 Dec 12.
9
Nomogram to predict the benefit of additional induction chemotherapy to concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: Analysis of a multicenter, phase III randomized trial.列线图预测局部晚期鼻咽癌同步放化疗中额外诱导化疗的获益:多中心 III 期随机试验分析。
Radiother Oncol. 2018 Oct;129(1):18-22. doi: 10.1016/j.radonc.2017.12.002. Epub 2017 Dec 16.
10
PET/CT-guided dose-painting versus CT-based intensity modulated radiation therapy in locoregional advanced nasopharyngeal carcinoma.18F-FDG PET/CT引导的剂量引导放疗与基于CT的调强放疗在局部晚期鼻咽癌中的应用比较
Radiat Oncol. 2017 Jan 13;12(1):15. doi: 10.1186/s13014-016-0739-y.